One Chain Immunotherapeutics

@onechaintx

Spin-off company of the @Menendez_Lab, @CarrerasIJC & @icreacommunity, aiming to develop CAR-T candidates as a treatment for oncological diseases.

onechaintx.com

Joined September 2020

764 Following

1,332 Followers

Replies Reposts Media

One Chain Immunotherapeutics
@onechaintx
Oct 5
In Vivo CAR-T therapy has many benefits, this is why at OneChain, we’ve developed a next-generation lentiviral in vivo CAR-T platform. Learn more about it in the infographic, or visit lnkd.in/d3DWa6fP #CART #AdvancedTherapies #Biotech
One Chain Immunotherapeutics
@onechaintx
Sep 16
Patient recruitment is ongoing for the CARxALL clinical trial evaluating OC-1, our investigational CD1a-directed CAR-T therapy for relapsed or refractory T-ALL/T-LL. Learn more about OC-1 and the CARxALL trial: lnkd.in/efnZzdhk
One Chain Immunotherapeutics
@onechaintx
Sep 3
Next week, we will be at #ATE26 sharing the latest data from our next-generation lentiviral in vivo CAR-T platform. 🗓️ September 8th at 3 PM The session will be followed by a panel discussion. See you there! #AdvancedTherapies #CellTherapy #InVivoCART
One Chain Immunotherapeutics
@onechaintx
Aug 26
T-ALL/T-LBL remains a serious disease with limited treatment options when standard therapies fail. CAR-T cell therapies, like our investigational CD1a-directed CAR-T therapy, OC-1, can change that. Learn more about OC-1 and the clinical trial: lnkd.in/efnZzdhk
1
One Chain Immunotherapeutics
@onechaintx
Aug 18
As the pace begins to slow down in August, we’ve taken a moment to look back at everything OneChain has already achieved in 2026. It’s been a year of scientific progress, meaningful collaborations, knowledge-sharing and growing recognition for our work in the CAR-T field. 🚀
00:00
Josep Carreras Leukaemia Research Institute (IJC) and 8 others